Information från ABG Sundal Collier

Här finner du information kring börsens mindre och medelstora bolag. Avsändare är ABG Sundal Collier, innehållet är inte skapat av placera.nu:s redaktion.

« Tillbaka

BTS Group - Much better than expected, stock up >10%

06 november 2026

<a id="bm-comp-0b1ac48e-3dd4-4f19-8017-400d874de685" name="bm-comp-0b1ac48e-3dd4-4f19-8017-400d874de685" class="BMCustomAnchor"></a><table><tr><td bm-component-id="0b1ac48e-3dd4-4f19-8017-400d874de685" style="vertical-align: top; width:100.000000%;"><ul><li>13% organic growth (cons 5%), EBITA +47% vs cons</li><li>Sales beat in all regions, AI implementation deals develop strongly</li><li>"Progressing towards 17% margin" (cons 13.7% 2028e), est &amp; stock up &gt;10%</li></ul></td></tr></table><a id="bm-comp-aae96830-0574-4bbe-a05e-f095d4a4effa" name="bm-comp-aae96830-0574-4bbe-a05e-f095d4a4effa" class="BMCustomAnchor"></a><table><tr><td bm-component-id="aae96830-0574-4bbe-a05e-f095d4a4effa" style="vertical-align: top; width:100.000000%;"><h3 class="bm-h3">Q3 details</h3><p>Sales SEK 716m (8% vs ABG 663m, 8% vs cons 666m), adj. EBITA 81m (45% vs ABG 56m, 47% vs cons 55m), adj. EBITA margin 11.4% (ABG 8.4%, cons 8.3%). Adj. EBITA +79% y-o-y (ABG 23%, cons 21%). Organic growth 13% (ABG 5%, cons 5%).</p><h3 class="bm-h3">Strong momentum, upside potential from margin target comment</h3><p>BTS delivered sales beat in all regions (+1-10% vs cons) with &gt;10% organic growth in North America (17%) and Europe (15%). Positive results from AI, both revenues from AI implementation projects (+13% q-o-q, now 11% of group sales) and improved internal efficiency. Reiterates FY guidance of &#8220;2026 EBITA significantly better than 2025&#8221;, which is the highest guidance level, and in line with expectations. Guides for a slow-down in Europe organic growth in Q4, also as expected. Comments that it expects solid organic growth ahead and is progressing towards the long-term EBITA margin target of 17% (cons 13.7% 2028e), which we find encouraging given that the margin has declined from peak 15.0% in 2021 to 11.2% in 2025 and 11.8% in 2026e (cons).</p><h3 class="bm-h3">Estimates and stock up &gt;10% today</h3><p>We expect consensus to raise EBITA by 10-15% and share to outperform significantly today, up &gt;10% on the strong organic growth and long-term margin comment. Conf call CET 9.00.</p></td></tr></table><a id="bm-comp-804e9b65-0e99-47a7-bffa-9e39f4f2def6" name="bm-comp-804e9b65-0e99-47a7-bffa-9e39f4f2def6" class="BMCustomAnchor"></a><table><tr><td bm-component-id="804e9b65-0e99-47a7-bffa-9e39f4f2def6" style="vertical-align: top; width:100.000000%;"><table id="bm-img-aa96d951-009d-469f-89a2-59d944d67a6f" class="bm-img-table xslt-img-empty xslt-img-include"><tr><td class="xslt-img-caption">Deviation</td></tr><tr><td><img bm-img-encrypt="aa96d951-009d-469f-89a2-59d944d67a6f" bm-img-original-height="1089" bm-img-original-width="838" bm-img-svg="image:image_upload/100364_ba598ffe-c551-4da3-b1d2-38a79a8edb18.svg" bm-img-width-hint="86.50%" id="bm-id-aa96d951-009d-469f-89a2-59d944d67a6f" src="https://abgsc.bluematrix.com/images/image_upload/100364_ba598ffe-c551-4da3-b1d2-38a79a8edb18_628.png" svg="/nas/web/clients/abgsc/images/image_upload/100364_ba598ffe-c551-4da3-b1d2-38a79a8edb18.svg" width="628" alt="" title="" /></td></tr><tr><td class="xslt-img-source">Source: ABG Sundal Collier, Capital IQ, company data</td></tr></table></td></tr></table>

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-11-19 Tempest Security - Growth returns but margins lag Tempest Sec.. Analys
2026-11-19 Coor - Restarts the M&A engine Coor Analys
2026-11-18 Eltel - CMD: Growth follows the margin repair Eltel Analys
2026-11-16 Petrolia Noco - Q3 impacted by underlift Petrolia Noco Analys
2026-11-16 Proact - CMD takeaways: Clear path to 2030 targets Proact Analys
2026-11-16 Donkey Republic - Wins 1,700-bike Karlsruhe contract Donkey Repu.. Analys
2026-11-16 Ogunsen - Back to growth with a leaner base Ogunsen Analys
2026-11-15 Isofol Medical - Clinical momentum builds ahead o... Isofol Medical Analys
2026-11-13 Clavister - Scaling up with civilian business nex... Clavister Analys
2026-11-12 Generic - Seasonality in volumes with margins hol... Generic Analys
2026-11-12 Xplora Technologies - Strong beat, but shouldn't ... Xplora Tech.. Analys
2026-11-12 Clavister - Scalability on full display Clavister Analys
2026-11-12 Generic - Softer growth but stronger earnings Generic Analys
2026-11-11 Ferronordic - The new normal Ferronordic Analys
2026-11-11 Proact - New targets include adj. EPS doubling 20... Proact Analys
2026-11-11 Ferronordic - Positive trend continues Ferronordic Analys
2026-11-10 Proact - Ahead of CMD Proact Analys
2026-11-10 G5 Entertainment - Estimates raised on lower costs G5 Entertai.. Analys
2026-11-10 Coor - Momentum building in Norway Coor Analys
2026-11-09 Generic - A broader base to grow from Generic Analys